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In the growth plate, the interplay between parathy-
roid hormone-related peptide (PTHrP) and Indian
hedgehog (Ihh) signaling tightly regulates chondro-
cyte proliferation and differentiation during longitu-
dinal bone growth. We found that PTHrP increases
the expression of Zfp521, a zinc finger transcriptional
coregulator, in prehypertrophic chondrocytes. Mice
with chondrocyte-targeted deletion of Zfp521
resembled PTHrP/ and chondrocyte-specific
PTHR1/ mice, with decreased chondrocyte prolif-
eration, early hypertrophic transition, and reduced
growth plate thickness. Deleting Zfp521 increased
expression of Runx2 and Runx2 target genes, and
decreased Cyclin D1 and Bcl-2 expression while
increasing Caspase-3 activation and apoptosis.
Zfp521 associated with Runx2 in chondrocytes,
antagonizing its activity via an HDAC4-dependent
mechanism. PTHrP failed to upregulate Cyclin D1
and to antagonize Runx2, Ihh, and collagen X expres-
sion when Zfp521 was absent. Thus, Zfp521 is an
important PTHrP target gene that regulates growth
plate chondrocyte proliferation and differentiation.
INTRODUCTION
In the growth plate, endochondral longitudinal bone growth
requires the tight regulation of entry into and exit from each stage
of chondrocyte differentiation, which correspond to the well-
defined resting, proliferative, prehypertrophic, and hypertrophic
zones. Alterations in this regulation disrupt the normal differenti-
ation program, resulting in distorted growth plate architecture
that leads to skeletal dysplasias with pronounced limb short-
ening (Kronenberg, 2003).DevelopmParathyroid hormone-related peptide (PTHrP) is a key regu-
lator of growth plate development (Kronenberg, 2006). It slows
the progression from proliferating cells to hypertrophy by
inducing Cyclin D1 expression, which promotes proliferation
(Beier et al., 1999, 2001), and by repressing expression of
Runx2 (Guo et al., 2006; Iwamoto et al., 2003; Li et al., 2004),
which drives chondrocyte differentiation (Kim et al., 1999; Zheng
et al., 2003). In addition to slowing the transition of prehypertro-
phic cells to the hypertrophic state, PTHrP promotes the survival
of hypertrophic chondrocytes by inducing the expression of the
anti-apoptotic protein Bcl-2 (Amling et al., 1997). Consequently,
genetic changes that eliminate (Amizuka et al., 1994; Lanske
et al., 1999) or constitutively activate (Schipani et al., 1997; Weir
et al., 1996) PTHrP-induced signaling result in major alterations
in the structure of the growth plate and longitudinal bone growth.
Zfp521 (also known as Evi3 in mice, EHZF in humans) is
a 180 kDa transcriptional coregulator that contains 30 Kru¨ppel-
like C2H2 zinc fingers (Bond et al., 2004; Justice et al., 1994).
Zfp521 is highly expressed in hematopoietic and neural stem
cells. Although the role of Zfp521 in the coordination of neuronal
differentiation is still elusive, it is thought to have an inhibitory
function in hematopoietic stem cell differentiation because over-
expression of Zfp521 favors the expansion of hematopoietic
progenitors while blocking their differentiation (Bond et al.,
2004). In hematopoiesis and oncogenesis, Zfp521 exerts some
of its main effects on B cells and erythrocyte maturation by
binding and antagonizing Ebf (Bond et al., 2008; Matsubara
et al., 2009). In murine B cell lymphomas, the Zfp521 gene is
frequently altered by retroviral insertions adjacent to the initiation
codon, which leads to increased expression of the proteins
(Warming et al., 2003). Significant levels of Zfp521 transcript
are also found in several human acute myeloid leukemias
(Bond et al., 2008; Yamasaki et al., 2010), suggesting that altered
Zfp521 activity contributes to these human hematological malig-
nancies, possibly by increasing tumor resistance to NK cells
(La Rocca et al., 2009).
We recently observed that PTHrP regulates Zfp521 expres-
sion in osteoblasts and osteocytes, where Zfp521 repressesental Cell 19, 533–546, October 19, 2010 ª2010 Elsevier Inc. 533
Figure 1. Zfp521 Expression during Skeletal Development
Whole tibia at E12.5 (A) (253) and E14.5 (B) (103) and proximal tibia growth plate at E17.5 (C–G) (103) and 2 weeks (H) (103) were immunostained with an anti-
body against Zfp521 (A–C and H), PTHR1 (D), or collagen type X (F) or with hematoxylin and eosin (G). (A) Zfp521 was highly expressed throughout the cartilage
anlage. (B) Zfp521 staining decreased in the forming primary center of ossification (arrow). (C–E) In the formed growth plate, Zfp521 and PTHR1 were most highly
expressed in prehypertrophic chondrocytes. Prol, proliferative; Pre, prehypertrophic; Hyp, hypertrophic.
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Zfp521 Mediates PTHrP Effects on ChondrocytesRunx2’s transcriptional activity and, indirectly, expression (Wu
et al., 2009). In situ hybridization (ISH) also revealed Zfp521
expression around mesenchymal condensations as early as
E12.5, in the perichondrium and in early chondrocytes, and in
the developing growth plate (Wu et al., 2009). Based on its
pattern of expression, its response to PTHrP, and its effects
on Runx2, we hypothesized that Zfp521 could regulate growth
plate development, possibly downstream of PTHrP. We now
report that Zfp521 is an important downstream effector of
PTHrP in the regulation of chondrocyte proliferation and differ-
entiation in the growth plate, ensuring proper postnatal longitu-
dinal bone growth.
RESULTS
Zfp521 Is Highly Expressed in Prehypertrophic
Chondrocytes
Immunostaining of developing long bones showed expression of
Zfp521 as early as E12.5 in all chondrocytes within the cartilage
anlage (Figure 1A). At E14.5, Zfp521 expression decreased in the
area of hypertrophic differentiation (Figure 1B). During the late
stages of embryonic development (E17.5) (Figure 1C) and
postnatally at 2 weeks (Figure 1H), Zfp521 was preferentially
expressed within the growth plate in prehypertrophic chondro-
cytes, where it colocalized with the peak expression of the
PTHrP receptor (PTHR1) (Figures 1D and 1E).
Deleting Zfp521 in Chondrocytes Affects Longitudinal
Bone Growth and the Structure of the Growth Plate
To examine its role in the growth plate, we deleted Zfp521 in
chondrocytes using Cre recombinase driven by the collagen II
promoter (Col II-Cre) (Long et al., 2001). The deletion efficiency
was confirmed in primary rib chondrocytes by qPCR (see
Figure S1A available online). Although Zfp521fl/fl Cre+ (cKO)
mice were similar to floxed-control (Zfp521fl/fl Cre-) mice at birth534 Developmental Cell 19, 533–546, October 19, 2010 ª2010 Elsev(Figure S1B), growth retardation was evident by 1–2 weeks of
age (Figure 2A) and still present at 8 weeks (Figure S1E) and
12 weeks (data not shown). Consistent with the pattern of Col
II expression, bones that formed by endochondral ossification
were smaller, whereas craniofacial structures that develop by
intramembranous ossification and the cranium base syn-
chondroses appeared normal (Figures S1C and S1D). No other
gross anatomical alterations were seen in the Zfp521 cKO mice.
Histomorphometric analysis of proximal tibia from 2-week-old
mice revealed a 30% reduction in the mutant growth plate thick-
ness, affecting all zones (Figures 2B and 2C). The resting zone
contained only one or two layers of cells, rather than five or
more layers in the Zfp521fl/flCre- growth plates. Proliferating cells
were properly oriented along the long axis of the bone and had
a normal flat morphology, but the number of cell columns and
cells per column were reduced (Figure 2D). The transition to
the hypertrophic zone was closer to the epiphysis. The hypertro-
phic zone thickness was also reduced (Figures 2B and 2C) with
fewer chondrocytes, each of increased cellular height (Figures
2D and 2E), and about 50% less extracellular matrix (ECM)
(Figures 2F and 2H), resulting in a reduced matrix-to-cell ratio
(Figure 2G), suggesting impaired matrix production. The onset
of ECM mineralization also occurred prematurely (Figure 2I),
due to decreased proliferation, accelerated differentiation, or
both. Consequently, whereas an average of six layers of hyper-
trophic chondrocytes were present between the prehypertro-
phic chondrocytes and the leading edge of the mineralization
front in the Zfp521fl/fl Cre-, only three layers were present in the
cKO mice.
In situ hybridization confirmed the altered growth plate archi-
tecture in the absence of Zfp521 (Figure 3). Reduction in the
thickness of the entire growth plate and the proliferative and
hypertrophic zones were revealed by Col II expression
(Figure 3A), the hedgehog receptor subunit patched (Ptc)
(Figure 3B), and Col X, respectively (Figure 3C). Indian hedgehogier Inc.
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Figure 2. Deleting Zfp521 in Chondrocytes Alters Growth Plate Structure and Skeletal Development
(A) Two-week-old Zfp521 cKO mice (right) exhibited postnatal dwarfism. Rib cage, long bones, and vertebrae of the Zfp521 cKO mice were smaller than in the
floxed control.
(B) Proximal tibia growth plates from 2-week-old mice were stained with safranin O (103). A reduction in the thickness of all layers was observed in the Zfp521
cKO growth plates (r, resting; p, proliferative; h, hypertrophic). In addition the hypertrophic zone was closer to the epiphysis (yellow arrows), suggesting early
hypertrophic differentiation.
(C–H) Data derived from Zfp521 cKO mice are shown in white, and data obtained in floxed control mice are presented in black (C) Histomorphometric analysis
of proximal tibia growth plates from the Zfp521 cKO and floxed control mice confirmed an approximate 30% reduction in the thickness of all layers. Also,
there were fewer cell columns with fewer cells per column in the proliferative zone (339 ± 48 versus 193 ± 28) and a reduced cell population in the hyper-
trophic zone (157 ± 21 versus 105 ± 27) (D). (E) The cell height of hypertrophic chondrocytes in Zfp521 cKO growth plates was increased (17.7 ± 2.7 mm
versus 23.7 ± 2.9mm), whereas proliferative chondrocytes were similar in floxed control and mutant growth plates. (F) The percentage of the hypertrophic
zone volume occupied by ECM was reduced in mutant growth plates (31% ± 0.02% versus 16% ± 0.07%), a comparable increase in the percentage occu-
pied by cells (69% ± 0.02% versus 84% ± 0.07%), which generated a decrease in the ECM/cell ratio (0.44 ± 0.05 versus 0.20 ± 0.07) (G). (H) The expression
of aggrecan mRNA is reduced by about 50% in the growth plate of Zfp521 cKO mice.
(I) von Kossa staining showed earlier chondroid mineralization (black) in the Zfp521 cKO growth plates. Note the reduction in the number of layers of hyper-
trophic chondrocytes between the prehypertrophic chondrocytes and the leading edge of the mineralization front (yellow and blue lines). Data are
means ± SD, n = 4, p < 0.05.
Developmental Cell
Zfp521 Mediates PTHrP Effects on Chondrocytes(Ihh) and PTHR1, both markers of prehypertrophic cells, were
upregulated and located closer to the epiphysis than in the
control (Figures 3D and 3E). Quantitative PCR of mRNA isolated
from Zfp521 cKO and Zfp521fl/fl Cre- mice growth plate chondro-
cytes confirmed the ISH results (Figures 3F–3J).DevelopmZfp521 Regulates Chondrocyte Proliferation
Cell proliferation was decreased in the Zfp521 cKO growth
plate (40% ± 5% BrdU-positive cells in Zfp521fl/fl Cre- mice,
28% ± 3% in the cKO mice, p < 0.005) (Figures 4A and 4B). In
ATDC5 cells, depleting Zfp521 with shRNA (Figure S2A)ental Cell 19, 533–546, October 19, 2010 ª2010 Elsevier Inc. 535
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Figure 3. ISH of Differentiation Markers
(A–E) ISH (left panels) including quantification (right panels) of proximal tibiae from 2-week-old Zfp521 cKO and floxed control (Cre-) mice (103). (A) The Collagen
type II (Col II) signal in the cKO growth plate was thinner (25% ± 2% reduction), demonstrating the overall thinning of the growth plate. The signals for Ptc (B) and
Collagen type X (Col X) (C) revealed the narrower proliferative (34.3% ± 3% reduction) and hypertrophic (20.7% ± 3% reduction) zones, respectively. Prehyper-
trophy markers Ihh (D) and PTHR1 (E) demonstrated the closer proximity of the prehypertrophic zone to the epiphysis (35.9% ± 2% and 32.9% ± 3% reduced
distance between markers and top of the growth plate, respectively). Quantification of the granular area fraction covered by Col X, PTHR1, and Ihh signal, as
described in Experimental Procedures, revealed changes of 6-fold reduction, 3-fold increase, and 1.7-fold increase, respectively, in the Zfp521 cKOgrowth plate.
Data are means ± SD.
(F–J) qPCR of mRNA isolated from floxed and mutant growth plate chondrocytes are presented.
Developmental Cell
Zfp521 Mediates PTHrP Effects on Chondrocytesincreased the doubling time and decreased bothmicromass size
and BrdU incorporation (Figures S2B–S2D), whereas forced
expression of Zfp521 increased BrdU incorporation by about
50% (Figures S2E and S2F). Neither transient overexpression
of Zfp521 in fibroblastic NIH 3T3 cells, nor stable depletion of
Zfp521 in osteoblastic MC3T3-E1 cells altered BrdU incorpora-
tion (Figures S2G and S2H), demonstrating that the effect of
Zfp521 on cell proliferation is chondrocyte specific.
Cyclin D1 promotes chondrocyte proliferation, and Cyclin
D1-deficient mice exhibit a thin proliferative zone (Beier et al.,
2001).We founddecreasedproliferation in primary chondrocytes
from Zfp521 cKO mice (data not shown), confirming our in vivo
results, and decreased expression of Cyclin D1 (Figure 4C). Simi-
larly, depleting Zfp521 reduced Cyclin D1 expression in ATDC5536 Developmental Cell 19, 533–546, October 19, 2010 ª2010 Elsevcells (Figure 4D), whereas forced expression of Zfp521 increased
both mRNA and protein levels of Cyclin D1 (Figure 4E). These
results suggest that Zfp521 promotes Cyclin D1 expression,
contributing to keeping growth plate chondrocytes in a prolifera-
tive state, although we found that Zfp521 did not affect the
activity of a Cyclin D1-luciferase reporter gene in ATDC5 cells
(data not shown), suggesting that the changes in Cyclin D1
expression that occurwhenZfp521 is depleted or overexpressed
are not the result of a direct effect on the Cyclin D1 promoter.
Zfp521 Slows the Progression of Chondrocytes
to Hypertrophy
Because growth plate development requires a balance between
chondrocyte proliferation and progression to hypertrophy, weier Inc.
Developmental Cell
Zfp521 Mediates PTHrP Effects on Chondrocytesnext examined the effect of Zfp521 on alkaline phosphatase
(ALP) activity, an early hypertrophy marker. Overexpressing
a tetracycline (tet)-inducible Zfp521 in ATDC5 cells from day 0
until day 16 of culture, i.e., before the transition to hypertrophy,
repressed the formation of Alcian blue-positive cartilage nodules
(Figure 4F upper panel), suggesting impaired chondrogenic
differentiation. Overexpression from day 16 until day 30, i.e., at
the time of hypertrophic transition and beyond, induced a signif-
icant decrease in ALP activity (Figure 4F lower panel). Thus,
Zfp521 appears to antagonize hypertrophic differentiation as
well as promoting chondrocyte proliferation.
Zfp521 Antagonizes Runx2 Activity in Chondrocytes
Runx2 is a key promoter of chondrocyte hypertrophy. Therefore,
we assayed the expression of Runx2 and its target genes in
cultured primary rib chondrocytes from Zfp521 cKO and
Zfp521fl/fl Cre- mice. The expression of Runx2, Ihh, osteopontin
(OPN), ALP, and MMP-13 all increased in the absence of Zfp521
(Figure 4G). Consistent with the ISH results, and despite the fact
that it is also considered a Runx2 target gene, expression of the
matrix component Col Xwas decreased by about 50%, suggest-
ing that Zfp521 also regulates Col X gene expression by Runx2-
independent mechanisms.
We next examined the effect of Zfp521 on Runx2 expression in
MCT cells, an immortalized chondrocyte cell line that rapidly
becomes hypertrophic at nonpermissive temperatures (Zheng
et al., 2003). As expected, inducing hypertrophic differentiation
increased the expression of Runx2 significantly (data not
shown). Transiently transfecting MCT cells with Zfp521 prior to
inducing hypertrophy reduced Runx2 as much as treating with
PTHrP and Forskolin (Figure 4H), confirming the ability of
Zfp521 to suppress Runx2 expression.
We have previously shown that Zfp521 associates with Runx2
and antagonizes its transcriptional activity in osteoblasts (Wu
et al., 2009). Endogenous Zfp521 also immunoprecipitated with
Runx2 from ATDC5 and MCT cells (Figure 4I). Therefore, we
examinedwhether Zfp521 also regulatedRunx2 activity in hyper-
trophic chondrocytes and found that Zfp521 dose-dependently
repressed Runx2-induced activation of the 6xOSE2-luc reporter
plasmid in MCT cells during temperature-induced hypertrophic
differentiation, (Figure 4J), indicating that Zfp521 also controls
Runx2 transcriptional activity in differentiating chondrocytes.
Repression of Chondrocyte Runx2 Activity by Zfp521
Requires HDAC4
Several histone deacetylases (HDACs) antagonize Runx2 (Kang
et al., 2005; Schroeder et al., 2004; Westendorf et al., 2002), and
it has been reported that HDAC4 binds and antagonizes Runx2 in
prehypertrophic chondrocytes (Vega et al., 2004) and that PTHrP
induces the nuclear translocation of HDAC4 (Kozhemyakina
et al., 2009). Therefore, we looked for a possible connection
between Zfp521 and HDAC4 and found that the two proteins
form an endogenous complex in ATDC5 cells (Figure 4K) and
that depleting HDAC4 blunted the Zfp521-induced Runx2
repression (Figure 4L).
Zfp521 Regulates Chondrocyte Apoptosis
Apoptosis of hypertrophic chondrocytes is another key event in
growth plate development. The reduced number of hypertrophicDevelopmcells suggested that Zfp521 might antagonize chondrocyte
apoptosis. As hypothesized, the number of apoptotic hypertro-
phic chondrocytes increased about 3-fold in the Zfp521 cKO
growth plate (Figure 5A). Induction of apoptosis culminates in
increased caspase activity, especially Caspase-3 (Porter and
Janicke, 1999), and indeed, caspase activity was increased in
Zfp521 cKO primary chondrocytes (Figure 5B top panels). Simi-
larly, caspase activity and activatedCaspase-3 protein in ATDC5
cells were increased by depleting Zfp521 (Figure 5B middle
panels and Figure 5C) and decreased by overexpressing
Zfp521 (Figures 5B [bottom panels] and 5D). Finally, we found
that expression of the anti-apoptotic protein Bcl-2, which
enhances survival of terminally differentiated chondrocytes
(Amling et al., 1997), was significantly decreased in primary
chondrocytes from Zfp521 cKO mice (Figure 5E). Thus, our
results suggest that Zfp521 antagonizes chondrocyte apoptosis.
PTHrP Regulates Zfp521 Expression in Differentiating
Chondrocytes
Our results consistently demonstrated that Zfp521 regulates
growth plate chondrocyte proliferation, differentiation, and
apoptosis. The reduced proliferation and early transition to
hypertrophy in Zfp521 cKO growth plates are reminiscent of
the effects of decreased PTHrP signaling in chondrocytes (Ami-
zuka et al., 1994; Kobayashi et al., 2002; Lanske et al., 1999).
Therefore, we examined whether Zfp521 played a role in the
responses of chondrocytes to PTHrP.
Consistent with the in vivo localization of Zfp521 in prehyper-
trophic chondrocytes (Figure 1H), the expression of endogenous
Zfp521 paralleled the temporal and spatial expression of endog-
enous PTHR1 in ATDC5 micromass and pellet cultures
(Figure S3), with peaks of expression coinciding during the
hypertrophic transition of ATDC5 cells and the highest respon-
siveness to PTHrP (Shukunami et al., 1996). Transient overex-
pression of Zfp521 in ATDC5 micromass cultures caused
a significant decrease in the number of Alcian blue-positive
nodules after 2 weeks, comparable to the decrease in cultures
treated with PTHrP (1-34) (Figure 6A). The inhibitory effects of
PTHrP (1-34) and Zfp521 on nodule formation were not additive,
suggesting that PTHrP and Zfp521 share the same signaling
pathway.
Given the similar expression patterns of Zfp521 and PTHR1 in
chondrocytes in vivo and in vitro, and their comparable inhibitory
effects on chondrocyte differentiation, we hypothesized that
Zfp521 could be an effector downstream of PTHrP. Indeed,
PTHrP (1-34) increased Zfp521 expression dose dependently
(Figure 6B) and time dependently (Figures 6C and 6D). Forskolin
had a similar effect, and the selective PKA inhibitor H-89 pre-
vented the induction of Zfp521 expression by both PTHrP
(1-34) and forskolin (Figure 6E), indicating that the Gas/cAMP/
PKA signaling pathway couples PTHrP to Zfp521 expression.
In contrast to the effect of PTHrP (1-34), PTHrP (7-34), which
selectively activates PLC-g signaling (Nutt et al., 1990), downre-
gulated Zfp521mRNA and protein levels in a similar time-depen-
dent manner (Figures 6F and 6G). Stimulating protein kinase C
directly with 12-O-tetradecanoylphorbol-13-acetate (TPA)
achieved a similar reduction (Figure 6H), suggesting that the
PTHrP-induced PLC-g signaling pathway might oppose cAMP/
PKA in the regulation of Zfp521 downstream of PTHR1.ental Cell 19, 533–546, October 19, 2010 ª2010 Elsevier Inc. 537
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Figure 4. Zfp521 Regulates Chondrocyte Proliferation and the Expression of Hypertrophy and Terminal Differentiation Markers
(A) Two-week-old floxed control and Zfp521 cKOmice were injected with BrdU labeling solution (1 ml/100 g body weight) 20 and 4 hr before sacrifice, and prox-
imal tibia were immunostained for BrdU.
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Developmental Cell
Zfp521 Mediates PTHrP Effects on ChondrocytesZfp521 expression was also reduced in primary rib chondro-
cytes from PTHrP/ mice (Figure 6I) and increased in primary
rib chondrocytes from mice that overexpress the mutated
human PTHR1 that constitutively activates adenylyl cyclase
(Schipani et al., 1997) (Figure 6J). Together with the results
from the ATDC5 cultures, these data firmly establish that PTHrP
induces the expression of Zfp521 in chondrocytes.Zfp521 Contributes to the Effects of PTHrP
on Chondrocytes
PTHrP induces Cyclin D1 expression and proliferation (Beier
et al., 1999, 2001) and downregulates Runx2 expression (Guo
et al., 2006; Li et al., 2004) (Figure 7A), whereas deleting
Zfp521 decreased proliferation and Cyclin D1 expression and
increased Runx2 expression. The induction of Zfp521 expres-
sion by PTHrP suggested that Zfp521 mediated at least part of
PTHrP’s effects on chondrocyte proliferation and Runx2 expres-
sion. As hypothesized, we found that the loss of Zfp521
prevented the PTHrP (1-34)-induced upregulation of Cyclin
D1 mRNA (Figure 4C). We also found that although PTHrP
(1-34) downregulated the expression of Runx2 in ATDC5 cells
at the beginning of the hypertrophic conversion (Figure 7A) and
in primary chondrocytes from Zfp521fl/fl Cre- mice (Figure 7B)
as expected, it failed to reduce Runx2 expression when
Zfp521 was absent (Figures 7B and 7C). Finally, the absence
of Zfp521 also increased constitutive Ihh expression in primary
chondrocytes and prevented PTHrP’s downregulation of Ihh
(Figure 7D), identifying another downstream response to PTHrP
that requires Zfp521 and indicating the potential importance of
Zfp521 in the negative feedback loop that controls hypertrophy.
To evaluate the effect of Zfp521 deletion on PTHrP’s control of
hypertrophy, metatarsals from 2-week-old Zfp521 cKO and
control Zfp521fl/fl Cre- mice were cultured for 10 days with or
without PTHrP (1-34), and expression of Col X, a hypertrophic
marker that is downregulated by PTHrP, was examined by ISH
(Figure 7E). PTHrP effectively repressed the expression of Col
X mRNA in controls, but deletion of Zfp521 blunted the effect
of PTHrP on Col X expression, providing more evidence of the(B) Zfp521 cKO growth plates contained significantly fewer BrdU-positive chond
(C) Rib chondrocytes and growth plate chondrocytes (inset) isolated from floxed
48 hr. The lack of Zfp521 decreased Cyclin D1 expression in untreated chondrocy
NS, not significant.
(D) Zfp521 shRNA (seq 4) reduced Cyclin D1 expression in ATDC5 cells cultured
(E) Doxycycline-induced overexpression of Zfp521 in micromass cultures of ATDC
(graph) and protein (western blot).
(F) tet-inducible Zfp521-overexpressing ATDC5 cells and LacZ control cells were
Alcian blue (upper panel) or from days 16 to 30 and stained for ALP activity (l
blue-positive cartilage nodules and ALP activity.
(G) Primary rib chondrocytes isolated from floxed controls (black bars) and Zfp52
the expression of Runx2 and its target geneswas analyzed by qPCR. The expressi
chondrocytes. Col X expression was reduced by 50%.
(H) Overexpressing Zfp521 in MCT cells reduced Runx2 expression to the same e
additive.
(I) Co-immunoprecipitation of endogenous Zfp521 and Runx2 in ATDC5 and MC
(J) 6xOSE2-luc reporter assay showing Zfp521 dose-dependently repressing the
(K) Co-immunoprecipitation of endogenous Zfp521 and HDAC4 in ATDC5 cells.
(L) 6xOSE2-luc reporter assay demonstrating that Zfp521 requires HDAC4 to effec
down efficiency by siRNA transiently transfected into MCT cells before hypertroph
icant difference from control, #p < 0.05 significant difference from indicated con
Developmrole of Zfp521 downstream of PTHrP in controlling the transition
to hypertrophy in the growth plate.Zfp521 Represses PTHR1 Expression
in Prehypertrophic Chondrocytes
In addition to Zfp521 expression being regulated by PTHrP
downstream of PTHR1, we observed that PTHR1 expression
wasmarkedly increased in the Zfp521 cKO growth plate (Figures
3E and 3J), suggesting that Zfp521 downregulates PTHR1
expression in prehypertrophic chondrocytes. We confirmed
this by showing that depleting Zfp521 in ATDC5 cells increased
PTHR1 protein (Figure S4A), whereas overexpressing Zfp521 in
ATDC5 cells and MCT cells reduced PTHR1 protein (Figures
S4B and S4C). These data suggest that Zfp521mediates a nega-
tive feedback loop that downregulates PTHR1 expression in
prehypertrophic chondrocytes, thereby further contributing to
the regulation of PTHrP effects on the growth plate.DISCUSSION
Postnatal longitudinal bone growth depends on chondrocyte
proliferation and differentiation in the growth plate, a process
that is tightly controlled by PTHrP and Ihh (Kronenberg, 2003).
Zfp521 is a 180 kDa 30 Kru¨ppel-like zinc finger protein that
regulates the differentiation of neurons, hematopoietic cells,
and osteoblasts (Bond et al., 2004; Warming et al., 2003; Wu
et al., 2009). We now report that Zfp521 is also expressed in
growth plate chondrocytes and plays a role in the regulation
of their proliferation, differentiation, and apoptosis in response
to PTHrP. Targeted deletion of Zfp521 in chondrocytes led to
postnatal growth retardation with reduced thickness of all
growth plate zones. Zfp521 cKO chondrocytes exhibited
decreased proliferation, early hypertrophic transition, reduced
matrix production, and enhanced apoptosis. Deletion of
Zfp521 also decreased the expression of Cyclin D1 and
increased the expression of Runx2 and several Runx2 target
genes. Also, Bcl-2 expression decreased and caspase-3 activa-
tion increased when Zfp521 was absent. The decreasedrocytes than controls.
control and cKO mice were cultured with or without PTHrP (1-34) (100 nM) for
tes and abolished the PTHrP (1-34)-induced increase in Cyclin D1 expression.
in micromass for 10 days.
5 cells stably transfected with tet-inducible Zfp521 increased Cyclin D1mRNA
cultured in the presence of 0.5 mg/ml doxycycline for 16 days and stained with
ower panel). Overexpressing Zfp521 repressed both the formation of Alcian
1 cKO mice (white bars) were cultured for 3 days in maintenance medium, and
on of Runx2 and all target genes exceptCol Xwere increased in the Zfp521 cKO
xtent as PTHrP (1-34) (100 nM) and forskolin (10 mM), and the effects were not
T cells.
inductive activity of Runx2 in MCT cells.
tively repress Runx2 transcriptional activity in MCT cells. Inset, HDAC4 knock-
ic induction. (B–E, G, H, J, and L) Data are means ± SD, n = 3, *p < 0.05, signif-
dition.
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Figure 5. Zfp521 Regulates Chondrocyte Apoptosis
(A) TUNEL assay in 3-week-old proximal tibias from Cre- and cKO mice demonstrating an in vivo increased (3-fold) chondrocyte apoptosis in the absence of
Zfp521. Apoptotic cells are indicated (arrows).
(B) Primary rib chondrocytes isolated from Zfp521 cKO mice (top panels), Zfp521 shRNA-expressing ATDC5 cells (seq 4) (middle panels), and tet-inducible
Zfp521-overexpressing ATDC5 cells (bottom panels), and respective controls were stained for active caspase with FLICA (red). Nuclei were counterstained
with Hoechst stain (blue). Caspase activity was increased by deleting/depleting Zfp521 and decreased by overexpressing Zfp521. The percentage of
caspase-positive cells is indicated.
(C) Western blot of total cell lysates showed increased activated caspase-3 in Zfp521 shRNA-expressing ATDC5 cells (two different sequences) cultured for
12 days in chondrogenic conditions.
(D) Activated caspase-3 was decreased in doxycycline (0.5 mg/ml)-treated tet-inducible Zfp521-overexpressing ATDC5 cells.
(E) Bcl-2 mRNA expression was decreased in primary rib chondrocytes isolated from Zfp521 cKO mice. Data are means ± SD, n = 3, *p < 0.05, significant differ-
ence from floxed control.
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Zfp521 Mediates PTHrP Effects on Chondrocytesproliferation and consequent reduction in the number of cells
entering the differentiation program are likely key contributors
to the reduced thickness of all the zones of the Zfp521 cKO
growth plate. In addition the reduced matrix production and
increased apoptosis would also contribute to the thinning of
the growth plate.540 Developmental Cell 19, 533–546, October 19, 2010 ª2010 ElsevPTHrP is an essential regulator of chondrocyte proliferation,
differentiation, and life span in the growth plate during longitu-
dinal bone growth (Kobayashi et al., 2002; Kronenberg, 2006).
It controls the expression of at least three key regulatory
proteins: Cyclin D1 is increased to maintain proliferation
of early-stage chondrocytes (Beier et al., 1999, 2001); Runx2ier Inc.
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Figure 6. PTHrP Regulates Zfp521 Expression in Differentiating Chondrocytes
(A) Transiently transfected Zfp521 reduced the formation of Alcian blue-stained cartilage nodules in 12 day ATDC5 cell micromass cultures to the same extent as
100 nM PTHrP (1-34) (E.V., empty vector). Alcian blue staining was quantified spectrophotometrically after guanidine extraction.
(B) Continuous treatment of ATDC5 cells with PTHrP for 12 days dose dependently increased Zfp521 mRNA expression.
(C and D) PTHrP (1-34) (100 nM) and forskolin (10 mM) increased Zfp521mRNA expression in a time-dependent manner in ATDC5 cells treated either continuously
for 6, 12, or 18 days (C), or at the beginning of hypertrophic conversion (days 12 to 16) (D).
(E) The PKA inhibitor H-89 (10 mM) prevented the PTHrP- and forskolin-induced increase in Zfp521 mRNA expression in ATDC5 cells.
(F andG) Treatment of ATDC5 cells with 100 nMPTHrP (7-34) at the beginning of hypertrophic transition downregulated Zfp521mRNA (F), and protein (G) levels at
day 16.
(H) Treating ATDC5 cells with TPA (1 mM) continuously for 12 days to activate PKC downregulated the expression of Zfp521 mRNA.
(I and J) Zfp521 mRNA was decreased in primary rib chondrocytes isolated from PTHrP/ mice (I) and increased in primary rib chondrocytes from mice that
overexpress constitutively active PTHR1 (caPTHR1) (J), confirming that PTHrP/PTHR1 signaling induces Zfp521 expression. Data are means ± SD, n = 5,
*p < 0.05, significant difference from control.
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Zfp521 Mediates PTHrP Effects on Chondrocytes(and secondarily Ihh) expression is decreased to delay the onset
of the hypertrophic transition and initiation of matrix mineraliza-
tion (Guo et al., 2006); and Bcl-2 is increased to delay apoptosis
of hypertrophic chondrocytes (Amling et al., 1997).
Our results indicate that PTHrP also regulates the expression
of Zfp521 and that Zfp521 mediates some of the important
downstream effects of PTHrP in the growth plate. First, severalDevelopmeffects of overexpressing Zfp521 in chondrocytes resemble
changes induced by PTHrP, whereas the Zfp521 cKO growth
plate resembles the growth plates of the PTHrP KO and chon-
drocyte-specific PTHR1 KOmice (Amizuka et al., 1994; Kobaya-
shi et al., 2002). Second, PTHrP induced the expression of
Zfp521 in chondrocytes in a dose- and time-dependent manner,
similar to our observation in osteoblasts (Matsubara et al., 2009;ental Cell 19, 533–546, October 19, 2010 ª2010 Elsevier Inc. 541
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Figure 7. Zfp521 Mediates Some Effects of PTHrP on Chondrocytes
(A) Micromass cultures of ATDC5 cells were exposed to 100 nMPTHrP (1-34) or PTHrP (7-34) at the onset of hypertrophic conversion (days 12 to 16). PTHrP (1-34)
induced a progressive decrease in Runx2 mRNA expression, but PTHrP (7-34) had no effect.
(B) Primary rib chondrocytes were isolated from 2-week-old Zfp521 cKO and floxed control mice and treated for 48 hr with 100 nM PTHrP (1-34). PTHrP failed to
repress Runx2 mRNA expression in the Zfp521 cKO cells. NS, not significant.
(C) Micromass cultures of ATDC5 cells stably expressing Zfp521 (seq 4) or nontarget shRNAs were treated with 100 nM PTHrP (1-34) for 48 hr. Depleting Zfp521
prevented the PTHrP-induced decrease in Runx2 expression. NS, not significant.
(D) Ihh expression was measured in primary chondrocytes from 2-week-old Zfp521 cKO and floxed control mice treated for 48 hr with 100 nM PTHrP (1-34).
PTHrP failed to repress Ihh mRNA expression in the Zfp521 cKO cells. NS, not significant.
(E) Metatarsals from 2weeks old Zfp521 cKO and floxed control mice were cultured with or without PTHrP (1-34) for 10 days and assayed for Col XmRNA by ISH.
The absence of Zfp521 blunted the repressive effect of PTHrP on Col X expression. Note the presence of the growth plate phenotype onmutant metatarsals both
at days 0 and 10, and the alterations of the growth plate morphology of both wild-type and mutant mice at day 10 due to in vitro assay conditions.
(F) Proposed model of action of Zfp521 in prehypertrophic chondrocytes. In chondrocytes, activation of the parathyroid hormone (PTH) receptor 1 (PTHR1)
causes a PKA-mediated increase in Zfp521 expression and activates protein phosphatase 2A, which dephosphorylates HDAC4 (Kozhemyakina et al., 2009),
causing its nuclear accumulation. In the nucleus, Zfp521 forms a complex with HDAC4 and Runx2, leading to a repression of Runx2-mediated target gene
activation. (A–D) Data are means ± SD, n = 3, *p < 0.05.
Developmental Cell
Zfp521 Mediates PTHrP Effects on Chondrocytes
542 Developmental Cell 19, 533–546, October 19, 2010 ª2010 Elsevier Inc.
Developmental Cell
Zfp521 Mediates PTHrP Effects on ChondrocytesWuet al., 2009). Zfp521 expression in primary chondrocytes was
markedly decreased by deleting PTHrP and increased by
expressing the mutated PTHR1 that constitutively activates
adenylyl cyclase. Third, PTHrP failed to induce Cyclin D1 expres-
sion and to repress Runx2, Ihh, and Col X expression in chondro-
cytes when Zfp521 was absent, and Bcl2 expression, which is
induced by PTHrP in chondrocytes (Amling et al., 1997), was
also reduced in the absence of Zfp521. Thus, Zfp521 is a PTHrP
target gene that appears to be a key effector of PTHrP in mech-
anisms that modulate chondrocyte proliferation, differentiation,
and apoptosis in the growth plate.
The decreased cell proliferation is chondrocyte specific
because it was not seen in fibroblastic or osteoblastic cells,
and it is consistent with reports that Zfp521 acts to prevent
differentiation and increases early precursor pools within the
hematopoietic lineage (Bond et al., 2004; Warming et al.,
2003). Therefore, Zfp521 may function as a repressor of exit
from the cell cycle and progression to more mature cells.
Zfp521 may contribute to the regulation of chondrocyte prolifer-
ation by at least two mechanisms. First, Zfp521 promotes basal
Cyclin D1 expression in primary chondrocytes, which is required
for normal proliferation of growth plate chondrocytes, and medi-
ates the PTHrP-induced increase in Cyclin D1 expression,
although we found that Zfp521 did not affect the activity of
a Cyclin D1-luciferase reporter gene in ATDC5 cells (data not
shown), suggesting that the changes in Cyclin D1 expression
that occur when Zfp521 is depleted or overexpressed are not
the result of a direct effect on the Cyclin D1 promoter. Themech-
anism could involve modulating the coupling of PTHrP to CREB
(Beier et al., 2001) or possibly AP-1 factors, which we find bind to
Zfp521 (data not shown), or other factors (e.g., Ebf1) that have
been reported to interact with Zfp521. However, Cyclin D1
expression and chondrocyte proliferation are also induced by
Ihh (Long et al., 2001), and we cannot rule out a role for Zfp521
downstream of Ihh. Second, the inability of PTHrP to antagonize
Runx2 expression in the absence of Zfp521 and the resulting
elevated Runx2 expression could also contribute to the reduced
size of the proliferative zone because overexpressing Runx2
in proliferating and prehypertrophic chondrocytes reduces
proliferation and the thickness of the proliferative zone (Takeda
et al., 2001).
The repression of Runx2 expression by PTHrP, mediated by
cAMP/PKA, is a critical event in the normal regulation of the
chondrocyte hypertrophic transition (Iwamoto et al., 2003; Li
et al., 2004). Mice that lack Runx2 or overexpress a dominant-
negative form of Runx2 exhibit no hypertrophic conversion
(Inada et al., 1999; Ueta et al., 2001), whereas targeted overex-
pression of Runx2 in prehypertrophic chondrocytes accelerates
hypertrophic differentiation (Takeda et al., 2001). We confirmed
that PTHrP-induced activation of the cAMP/PKA pathway in
chondrocytes represses Runx2 expression and showed that it
also increases Zfp521 expression. More importantly, we found
that PTHrP failed to repress Runx2 expression in chondrocytes
when Zfp521 was absent. Consistent with the inhibitory effect
of Zfp521 on Runx2 transcriptional activity (Wu et al., 2009),
hypertrophic conversion was accelerated in the Zfp521 cKO
mice, with increased expression of ALP, Runx2, and the Runx2
target genes Ihh,MMP-13, andOPN, all markers of chondrocyte
differentiation, strongly suggesting that Zfp521 contributes toDevelopmthe PTHrP-induced repression of Runx2 expression and activity
in chondrocytes, and the resulting delay of hypertrophy.
HDACs inhibit gene expression by deacetylating both
histones (class I HDACs) and transcription factors (class II
HDACs) (Haberland et al., 2009). We found that the repression
of Runx2 activity by Zfp521 requires HDAC4. This class II
HDAC represses the transcriptional activity of Runx2 and
MEF2C, another key regulatory factor in prehypertrophic chon-
drocytes, and HDAC4 null mice display premature chondrocyte
hypertrophy (Vega et al., 2004), much like the effect of deleting
Zfp521 (this study) or the constitutive expression of Runx2 or
MEF2C in chondrocytes (Arnold et al., 2007). PTHrP induces
the nuclear translocation and repression of gene expression
by HDAC4 (Kozhemyakina et al., 2009). Our findings (1) that
PTHrP also induces Zfp521 expression and (2) that Zfp521
inhibits Runx2 transcriptional activity in an HDAC4-dependent
manner add another key element to this important growth plate
regulatory mechanism.
The last steps in the progression of chondrocyte differentiation
in the growth plate are the apoptosis of hypertrophic cells and the
replacement of cartilage by bone. PTHrP slows the onset of
chondrocyte apoptosis (Amizuka et al., 1996, 2004; Yamanaka
et al., 2003), consistent with our report that PTHrP signaling
increases the expression of the anti-apoptotic molecule Bcl-2
(Amling et al., 1997). Conversely,micewithCol II promoter-driven
Runx2 overexpression exhibit accelerated hypertrophic differen-
tiation and premature cartilage mineralization (Ueta et al., 2001),
and overexpression of Runx2 in primary chondrocytes increased
matrix calcification (Enomoto et al., 2000). Consistent with the
increased Runx2, we found that apoptosis of terminally differen-
tiated chondrocytes was increased in the Zfp521 cKO growth
plates, whereas Bcl-2 expression was decreased and Cas-
pase-3 activationwas increased inZfp521cKOprimary chondro-
cytes. This increased cell death presumably contributes to the
thinner hypertrophic zone of the Zfp521 cKO growth plate,
together with the reduced proliferation and production of matrix
proteins and the accelerated hypertrophic conversion.
Although the growth plate phenotype of the Zfp521 cKO mice
resembles that of the Col II-Cre: PTHR1fl/fl mice, it is less severe,
suggesting that not all PTHrP-induced regulatory mechanisms
depend on Zfp521 or that Zfp521 also modulates PTHrP-inde-
pendent mechanisms that regulate growth plate development.
A major difference is the time of presentation. Zfp521 cKO
newborns were little different from control littermates, in contrast
to the Col II-Cre: PTHR1fl/fl mice, in which the shortening of the
growth plate was well established by E17.5 (Kobayashi et al.,
2002). The lack of an embryonic phenotype in chondrocyte-
specific Zfp521 deletion was unexpected, given the clear co-
expression of Zfp521 and PTHR1 in prehypertrophic cells as
early at E17.5. However, deregulation or deletion of other regu-
latory molecules, e.g., constitutively active FGFR3 mutants
(Chen et al., 1999) and deletion of the growth hormone (GH)
receptor (Lupu et al., 2001), led to phenotypes that appear only
postnatally. Most relevant for this study, deletingCyclin D1 (Beier
et al., 2001) and overexpressing Runx2 (Takeda et al., 2001) both
cause a postnatal thinning of the growth plate similar to that in
the Zfp521 cKO mice, consistent with functional interaction of
the molecules. The absence of a phenotype seen in the
Runx2-overexpressing mice in late embryonic and perinatalental Cell 19, 533–546, October 19, 2010 ª2010 Elsevier Inc. 543
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Zfp521 Mediates PTHrP Effects on Chondrocytesstages, even though endogenous Runx2 expression is highest at
E14.5 (Inada et al., 1999; Takeda et al., 2001), suggests that
different Runx2-dependent mechanisms regulate growth plate
chondrocyte development in embryonic and postnatal growth
plates and that growth plate chondrocyte differentiation may
be more sensitive to high levels of Runx2 postnatally. Compen-
sation during embryogenesis for the loss of Zfp521 by the related
Zfp423, which is also expressed in chondrocytes, could also
contribute to the late onset of the phenotype.
In conclusion, our results demonstrate that the 30 Kru¨ppel-like
zinc finger protein Zfp521 contributes significantly to the regula-
tion of proliferation, hypertrophy, and apoptosis of growth plate
chondrocytes, thereby playing an important role in longitudinal
bone growth. Zfp521 accomplishes this in part by mediating
PTHrP-induced inhibition of Runx2 expression in prehypertro-
phic chondrocytes in an HDAC4-dependent mechanism
(Figure 7F). Zfp521 may also modulate other regulatory mecha-
nisms that control chondrocyte proliferation and apoptosis. In
the absence of Zfp521, the organization of the growth plate is
disturbed, and PTHrP responses are altered. Thus, Zfp521 is
an important regulator of growth plate differentiation and endo-
chondral bone development that is required for key downstream
responses to PTHrP.
EXPERIMENTAL PROCEDURES
Cell and Organ Cultures
ATDC5 cells were expanded and cultured in micromass as previously
described (Shukunami et al., 1996). The medium was changed every other
day and supplemented with PTHrP (1-34), PTHrP (7-34), forskolin, H-89, and
TPA as indicated. MCT cells were cultured as previously described (Zheng
et al., 2003). PTHrP (1-34) or forskolin was added to the cultures at the begin-
ning of the hypertrophic differentiation (nonpermissive temperature). Primary
chondrocytes were isolated from rib cages of mice, cultured as previously
described (Lefebvre et al., 1994), and treated with PTHrP (1-34) or PTHrP
(7-34) for 48 hr. Metatarsals from 2-week-old mice hind limbs were cultured
in a-MEM medium supplemented with 10% FBS, penicillin (100 U/ml), strep-
tomycin (100 mg/ml), and 1% L-glutamine with or without PTHrP (1-34) for
10 days in 37C/5% CO2, changing medium every other day. MC3T3-E1 cells
were cultured as previously described (Wu et al., 2009). NIH 3T3 cells were
cultured in DMEM supplemented with 10% BCS, penicillin (100 U/ml), and
streptomycin (100 mg/ml).
Gene Reporter Assay
MCT cells (23 105 cells/well in six-well plates) were cultured at 32C (permis-
sive temperature) until 70% confluent. Cells were transfected according to
manufacturer’s instructions using FuGene6 (Roche) in a 3:1 ratio with the
6xOSE2-Luc reporter plasmid along with combinations of Flag-Runx2
(0.5 mg), HA-Zfp521 (1 mg), HDAC4 siRNA (0.5 mg), and GAPDH siRNA
(0.5 mg) as indicated and adjusting the total amount of transfected DNA with
empty vector (pcDNA 3.1). Zfp521 dose response was assayed using
Zfp521:Runx2 ratios of 1:1, 3:1, and 5:1. pCMV-Renilla-luciferase (Promega)
(17 ng) was used for normalization. Transfected cells were cultured for 48 hr
at 37C/5% CO2 (nonpermissive temperature), and luciferase activity was
determined using the dual-luciferase reporter assay kit (Promega) following
manufacturer’s instructions. Results were calculated as fold activation over
empty vector control.
Coimmunoprecipitation Assay
Co-immunoprecipitation was performed essentially as described elsewhere
(Purev et al., 2009) using 2 mg mouse monoclonal anti-HDAC4 (Santa Cruz),
2 mg rabbit polyclonal anti-Zfp521 (Wu et al., 2009), or 2 mg anti-mouse IgG
antibody (Promega) and Protein A/G-agarose bead slurry (Santa Cruz). Beads
were collected by centrifugation and washed three to four times in mRIPA. The544 Developmental Cell 19, 533–546, October 19, 2010 ª2010 Elsevimmune complexes were boiled in 23 SDS-PAGE sample buffer and sub-
jected to immunoblot analysis.
tet-Inducible Zfp521 Overexpression System
ATDC5 cells stably transfected with tet-inducible Zfp521 were generated
using the T-Rex inducible system (Invitrogen) according to manufacturer’s
instructions. Doxycycline (0.5 mg/ml) was added to culture medium to induce
Zfp521 overexpression. ATDC5 cells stably transfected with tet-inducible
LacZ were used as control. mRNA was assessed by qPCR.
Zfp521 shRNA-Expressing Cells
Two ATDC5 cell lines that expressed Zfp521 shRNAs were created using
MISSION shRNA lentiviral transduction particles (Sigma-Aldrich) encoding
five different shRNA sequences (Broad Institute, Cambridge, MA, USA)
(protocol available at www.sigmaaldrich.com). ATDC5 cells were transduced
at 60% confluence (MOI 2 and 5) according to manufacturer’s instructions
and selected with puromycin (4 mg/m). Knockdown efficiency was evaluated
by measuring Zfp521 expression in 12 daymicromass cultures by qPCR. Cells
expressing either nontarget shRNA or TurboGFP control shRNAs were
prepared similarly. MC3T3-E1 cells stably expressing nontarget shRNA or
Zfp521 shRNA (sequence [seq] 4) were established similarly.
Generation of a Chondrocyte-Specific Zfp521 Conditional
Knockout Mouse
The Zfp521 gene was specifically deleted from chondrocytes by crossingmice
with a floxed Zfp521 gene locus (R.K., K.Y., H.S., E.H., D.C., A.A., W.C.H.,
N.A.J., N.G.C., S.W., and R.B., unpublished data) with mice that express the
Cre recombinase under the control of the Collagen type II (a1) promoter
(Long et al., 2001).
Growth Plate Histology and Histomorphometry
Hind limbs from 2-week-old Zfp521 cKO and floxed control mice were
dissected and processed for paraffin and methylmethacrylate embedding
with and without decalcification, respectively, as previously described (Wu
et al., 2009). Paraffin sections were stained with safranin O. von Kossa staining
of mineralized matrix was performed on methylmetacrylate sections after
plastic removal and analyzed under an inverted microscope (Maeda et al.,
2007). Growth plate histomorphometry was performed on safranin O-stained
sections of proximal tibia growth plates using Osteomeasure software (Osteo-
metrics–Decatur). A representative field at 403was used to obtain cell counts,
mean polar cellular axes (cell heights), and stereological volumetric estimators
obtained from measured areas (volume occupied by ECM and cells, respec-
tively, in thehypertrophic zone), asdescribedbyHunziker et al. (1987)withslight
modifications. Briefly, cumulative hypertrophic chondrocyte surface area was
measured and subtracted from the total hypertrophic zone surface area of
the field obtaining the ECM area component of the zone. The area measure-
ments served as volumetric stereological estimators of respective volumes.
Proliferation Assays
Two-week-old mice were injected intraperitoneally with 200 ml (1 ml/100 g of
body weight) of BrdU labeling reagent (Zymed Laboratories) 20 and 4 hr before
sacrifice. Incorporated BrdU was localized in proximal tibiae by immunohisto-
chemistry using the Cell Proliferation IHC kit, BrdU detection, with DAB visu-
alization (Chemicon) according to manufacturer’s instructions. Zfp521
shRNA-expressing ATDC5 cells and tet-inducible Zfp521 ATDC5 cells were
cultured on coverslips for 7 days and exposed to BrdU labeling reagent for
14 hr before fixing in 3.7% formaldehyde for 10min and BrdU immunolocaliza-
tion. BrdU incorporation was quantified using the Cell Proliferation ELISA kit,
BrdU detection (Chemicon). MC3T3-E1 cells stably expressing nontarget or
Zfp521 shRNA and NIH 3T3 cells transiently expressing empty vector
(pCMV2) or Zfp521 (pCMV2-Zfp521) were cultured on coverslips for 24 hr
and exposed to BrdU labeling reagent for 14 hr before BrdU immunolocaliza-
tion. Percentage of BrdU-positive cells was determined.
Caspase Activity and TUNEL Assay
105 primary rib chondrocytes were cultured on coverslips for 5 days.
105 shRNA-expressing ATDC5 cells or 105 ATDC5 cells stably transfected
with tet-inducible Zfp521 were cultured on coverslips in differentiationmediumier Inc.
Developmental Cell
Zfp521 Mediates PTHrP Effects on Chondrocyteswith or without doxycycline (0.5 mg/ml), respectively, for 1 week. Caspase
activity was assessed by fluorescence microscopy using the Sulforhodamine
FLICA Apoptosis Detection Kit Caspase Assay (Immunochemistry-Blooming-
ton) according to manufacturer’s instructions. TUNEL labeling was done using
an In Situ Death Detection Kit, Fluorescein (Roche) on paraffin-embedded
proximal tibiae sections, following manufacturer’s instructions. The number
of apoptotic cells was quantified.
In Situ Hybridization
35S-UTP-labeled riboprobes were synthesized from linearized plasmids using
the in vitro transcription kit (Promega) and 35S-UTP (Amersham). ISH using
antisense riboprobes was performed on 3.7% formaldehyde-fixed, decalci-
fied, paraffin-embedded proximal tibias of 2-week-old mice and metatarsal
bones as previously described (Razzaque et al., 2005). Image J 1.42q software
(Wayne Rasband, National Institutes of Health, Bethesda, MD, USA) was used
to calculate growth plate thicknesses and distances, measured in arbitrary
units and reported as percent changes, and the granular area fraction covered
by the ISH signal of Col X, PTHR1, and Ihh as a measure of the amount of
signal, and reported as fold change.
Statistical Analysis
Statistical differences were assessed with the unpaired Student’s t test. Data
are presented as mean ± SD, and p values less than 0.05 were considered
statistically significant.
Additional information about antibodies, transient transfections, quantitative
PCR, western blotting, immunohistochemistry, and Alcian blue/alizarin red
staining is included in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.devcel.2010.09.008.
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